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Introduction
Free radicals (reactive oxygen species) are well-
known to be involved in the development of various 
kinds of diseases, and it has been suggested that anti-
oxidant therapy with molecular hydrogen (H2) against 
free radicals may be useful for preventing diseases1). 
Many studies in the basic and clinical research fields 
have examined the usefulness of H2 as an anti-oxidant 
agent, through administration of H2-containing water, 
intravenous drip infusion of H2-r ich sal ine , or 
administration by inhalation of 2%-4% H2 gas2, 3). In 
particular, the effect of H2 gas as an anti-oxidant agent 
for many kinds of diseases has been examined, and H2 
gas is now acknowledged as a potentially strongly 
effective agent for the treatment of these diseases4).
In a previous study, we demonstrated rapid and 
significant increases of the salivary interleukin-1β (IL-1β) 
levels in healthy volunteers following administration by 
inhalation of a steam-mixed gas containing hydrogen 
gas (designated as XEN), generated by a machine 
(Suisonia) by decomposition of superheated steam; our 
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Abstract
   In a previous study, we demonstrated a significant increase in the salivary interleukin-1β (IL-1β) levels 
following the administration, via inhalation, of a steam-mixed gas containing hydrogen gas (designated as 
XEN) in healthy volunteers. In this study, we examined the salivary titers of immunoglobulin A2 (IgA2) 
directed against pathogenic hemagglutinin (HA) antigens derived from influenza virus strains 
(hereinafter, shortened to IgA2) after XEN administration by inhalation via a nasal cannula for 15 min in 
healthy volunteers. The salivary titers of IgA2 directed against HA antigens were measured using an 
originally constructed enzyme immunoassay system. The results indicated significant increases of the 
salivary IgA2 directed against the HA antigens derived from the following influenza virus strains after 
15 min of XEN inhalation, as compared to the titers recorded prior to the inhalation: A/
California/7/2009/H1N1 (P = 0.028), A/Hong Kong/4801/2014/H3N2 (P = 0.047), vaccine-type containing 
HA antigens derived from influenza virus strains, A/Singapore/GP1908/2015/H1N1, A/Hong 
Kong/4801/2014/H3N2, B/Texas/2/2013/Victoria system, and B/Phuket/1307/2013 /Yamagata system 
(P = 0.039). Taken together, XEN rapidly enhanced the salivary titers of IgA2  directed against HA 
antigens derived from influenza viruses, which may imply a role in the protection against influenza virus 
infection by activation of humoral immunity (IgA2 action) in the whole body via the nasal mucosal 
immune system.
Key words ：enzyme immunoassay, hemagglutinin (HA) antigen, salivary IgA2, steam-mixed gas 
containing hydrogen gas, XEN
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finding strongly indicated that XEN has immunological 
effects5). However, the effects of XEN inhalation on the 
production levels of salivary immunoglobulin A2 (IgA2), 
which is well-known to be resistant to and stable 
against a variety of proteolytic enzymes6), against 
pathogenic antigens, such as hemagglutinin (HA) 
antigens derived from influenza virus strains, have not 
yet been investigated. 
The aim of the present study was to analyze the 
effect of XEN inhalation on the salivary IgA2 response 
directed against HA antigens derived from influenza 
virus strains in healthy volunteers, and also discuss the 
potential effects, at the immunological level, of XEN 
inhalation in the living body. 
Materials and Methods
Reagents
Purified hemagglutinin (HA) antigen solutions (HA 
titer: 80-fold) derived from formalin-fixed influenza A 
virus strains, namely, A/California/7/2009/H1N1, A/
Hong Kong/4801/2014/H3N2 and vacc ine - type 
containing mixed HA antigens derived from influenza 
virus strains, A/Singapore/GP1908/2015/H1N1, A/
Hong Kong/4801/2014/H3N2, B/Texas/2/2013/
Victoria system, and B/Phuket/1307/2013 /Yamagata 
system (containing HA antigen 30 µg) were purchased 
from Denka Seiken Co., Ltd. (Niigata). Rabbit anti-
influenza A and B virus HA antigen-specific polyclonal 
IgG antibody was purchased from Takara Bio Co., Ltd. 
(Tokyo). Horseradish peroxidase (HRPOD)-conjugated 
mouse anti-human IgA2 monoclonal antibody (mAb) 
and HRPOD-conjugated goat anti-rabbit IgG antibody 
were purchased from MBL Co., Ltd. (Nagoya). 
Ethics statement 
The study protocol was approved by the institutional 
review board (IRB) of Kyushu University of Health and 
Welfare (IRB number 15-058). Informed consent was 
obtained from each of the volunteers prior to their 
participation in this study.
Steam-mixed gas containing H2 gas generator 
machine
 
A machine (Suisonia, FRJ-003) developed by Earth 
Engineering Co., Ltd. (Kitakyushu), that decomposes 
superheated steam to produce a steam-mixed gas 
containing H2 gas was used in this study. Steam-mixed 
gas containing H2 gas is named XEN at our laboratory
5).
 
Volunteers and saliva collection
Seventeen healthy adult volunteers without any 
abnormalities of the oral cavity (8 males, age 47.6 ± 
19.9 yr.; 9 females, age 39.1 ± 8.5 yr.) were enrolled for 
this study. Prior to the administration of XEN by 
inhalation, the subjects were asked to gargle and rinse 
their mouth (oral cavity) 15 times with water. About 40 
min later, they were seated on a chair, and XEN was 
administered by the inhaled route via a nasal cannula 
for 15 min. Thereafter, saliva samples were collected 
from the 17 volunteers. Briefly, saliva specimens were 
collected in 15-mL sterile tubes for two minutes. All 
the samples were then centrifuged at 3,000 rpm for 30 
min, and the supernatants were harvested and stored 
at -80°C until assay. 
Measurement of salivary IgA2 directed against 
HA antigens 
EIA plates (Sumitomo Co., Ltd., Tokyo) were coated 
with hemagglutinin (HA) antigen solutions derived 
from influenza virus strains at x20 dilution in 
carbonate-bicarbonate buffer (0.01 M NaCO3, 0.035 M 
NaHCO3, pH9.6) for 24 hrs at 4 °C. The wells were 
washed four times with phosphate-buffered saline 
(PBS) containing 0.05% Tween-20 (PBST) and blocked 
with PBST containing 2% BSA (BSA-PBST) for 60 min 
at room temperature. Thereafter, the wells were 
washed three times with PBST. Confirmation of HA 
antigen fixation to the wells of the EIA plates was 
performed by a binding assay using a rabbit anti-
influenza A and B virus HA antigen-specific polyclonal 
IgG antibody. The saliva specimens (x8 dilution with 
0.1% BSA-PBST; 50 µL) were then added to each well, 
followed by incubation for 60 min at room temperature 
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with shaking. The wells were washed five times with 
PBST, followed by addition of HRPOD-conjugated 
mouse anti-human IgA2 mAb (x3,000 dilution with 0.1% 
BSA-PBST; 50 µL) to each well and incubation of the 
wells for 60 min at room temperature with shaking. 
The wells were then washed 10 times with PBST, 
followed by addition of the substrate-chromogen (TMB; 
Cosmo Bio Co., Ltd.; 50 µL) to each well and incubation 
for 20 min at room temperature with gentle shaking. 
The reaction was stopped by the addition of 0.5 M HCl 
(50 µL), and the optical density (O.D.) was measured at 
450 nm using a multichannel EIA-microplate reader 
(TOSHO Co., Ltd.).
Statistical analysis
Data were analyzed by Wilcoxon’s paired t -test. 
Dif ferences at P <0.05 were considered to be 
statistically significant.
Results and Discussion
In this study, we examined the salivary titers of 
IgA2 directed against HA antigens derived from 
influenza A virus strains after XEN inhalation by an 
originally constructed EIA system in the 17 healthy 
volunteers. A significant and rapid increase of the 
salivary titers of IgA2 directed against HA antigens 
derived from A/California/7/2009/H1N1 and A/Hong 
Kong/4801/2014/H3N2 was observed as compared to 
the titers measured at the baseline (P = 0.028 and P = 
0.047, respectively) following XEN inhalation (Figs. 1 
and 2). Furthermore, the salivary titers of IgA2 
directed against mixed HA antigens (vaccine-type) 
derived from A/Singapore/GP1908/2015/H1N1, A/
Hong Kong/4801/2014/H3N2, B/Texas/2/2013/
Victoria system, and B/Phuket/1307/2013/Yamagata 
system also increased rapidly and significantly as 
compared to the titers measured at the baseline (P = 
0.039) (Fig. 3). The mean percent increases of the 
salivary titers of IgA2 directed against the HA 
antigens after XEN inhalation were 43.4% for the HA 
antigen derived from A/California/7/2009/H1N1, 28.0% 
f o r t h e HA an t i g e n d e r i v e d f r om A/Hong 
Kong/4801/2014/H3N2, and 63.9% for the vaccine-type 
HA antigens derived from A/Singapore/GP1908/2015/
H1N1 ,  A / H o n g K o n g /4801/2014/ H3N2 ,  B /
T e x a s / 2 / 2 0 1 3  / V i c t o r i a  s y s t e m ,  a n d  B /
Phuket/1307/2013 /Yamagata system (Fig. 4). On the 
other hand, no significant changes of the salivary IgA2 
titers were observed in the absence of XEN inhalation 
(data not shown).
It is common knowledge that IgA antibodies, which 
occur in monomeric and dimeric forms, play a crucial 
role in mucosal immunity7). The amount of IgA, which 
accounts for up to 15% of the total immunoglobulins, 
produced in mucosal membranes is greater than that 
of the other types of antibodies. Two subclasses of IgA 
are recognized ( IgA1 and IgA2) ; IgA1 occurs 
predominantly in the serum (>80%), while IgA2 is 
found mainly in maternal milk, tears, saliva8) and 
secretions from the gastrointestinal tract, prostate and 
respiratory epithelium. The dimeric forms of IgA1 or 
IgA2 bound by a joint protein (J-chain) and secretory 
component (SC) are called secretory IgA1 (sIgA1) and 
secretory IgA2 (sIgA2), respectively. In regard to the 
biological and structural properties, as IgA2, as 
compared to IgA1, is more resistant to and stable 
against a variety of proteolytic enzymes produced by 
microbes in the living body, IgA2 plays key roles in 
protection against many microbes in the living body6). 
Based on the above , in order to ana lyze the 
immunological IgA responses in the saliva, we selected 
an originally constructed EIA system for the detection 
of IgA2 in the saliva in this study. We found that the 
salivary titers of IgA2 directed against pathogenic HA 
antigens derived from influenza viruses clearly 
increased following XEN inhalation.
The precise mechanisms underlying the increase of 
the salivary titers of IgA2 directed against influenza-
virus-derived HA antigens after XEN inhalation remain 
unclear at present. However, we speculate on some 
possible mechanisms, as follows. XEN administered by 
inhalation via a nasal cannula induces activation of the 
nasal and oral mucosal immune systems, including in 
the mucosa-associated lymphoid tissues (MALTs)9) as 
immune-related organizations, resulting in increase in 
the salivary IgA2 levels. Alternatively, the increased 
salivary IgA2 titers may reflect activation of the 
immune system in the whole living body as protection 
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against influenza virus infection. These findings 
suggest the strong potential of XEN for development 
as a novel type of nasal mucosal vaccine for clinical 
application in the future10). 
In conclusion, we report, for the first time, that 
inhalation of XEN, a steam-mixed gas containing H
2 
gas, 
rapidly increased the salivary IgA2 response to 
influenza-virus-derived HA antigens. 
Disclosure
No authors have any conﬂict of interest.
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δ
Figure 1. Detection of salivary IgA2 directed against 
HA antigens derived from the A/California/7/2009/
H1N1 influenza virus strain.
　Detection of IgA2 in salivary samples (n = 17) 
directed against HA antigens derived from the A/
California/7/2009/H1N1 strain was performed using 
an originally constructed EIA system (See Materials 
and Methods for details). The measurements were 




Figure 2. Detection of salivary IgA2 directed against 
H A  a n t i g e n s  d e r i v e d  f r o m  t h e  A / H o n g 
Kong/4801/2014/H3N2 influenza virus strain.
　Detection of IgA2 in salivary samples (n = 17) 
directed against HA antigens derived from the A/
Hong Kong/4801/2014/H3N2 strain was performed 
using an originally constructed EIA system (See 
Materials and Methods for details). The measurements 
were repeated five times. P = 0.047 (before inhalation 
vs. after inhalation).
％
Figure 4. Mean percent increases of the salivary titers 
of IgA2 directed against HA antigens.
　The mean percent increases (MPIs) of the salivary 
titers of IgA2 directed against the HA antigens after 
XEN　inhalation as compared to those before XEN　
inhalation (n = 17) were calculated. The percent 
increases in each volunteer were calculated as follows. 
Percent increase (%) = {δOD value after inhalation - 
δOD value before inhalation)/δOD value before 
inhalation} x 100; then, the average values for the 
overall population (n = 17) were calculated. a: HA 
antigen derived from A/California/7/2009/H1N1; b: 
HA antigen derived from A/Hong Kong/4801/2014/
H3N2; c: vaccine-type HA antigens derived from A/
S i n g a p o r e /G P19 0 8/2 015/ H1N1,  A / H o n g 
Kong/4801/2014/H3N2, B/Texas/2/2013 /Victoria 
system, and B/Phuket/1307/2013 /Yamagata system.
δ
Figure 3. Detection of salivary IgA2 directed against 
mixed HA antigens (vaccine-type).
　Detection of IgA2 in salivary samples (n = 17) 
directed against mixed HA antigens (vaccine-type), 
consisting of the A/Singapore/GP1908/2015/H1N1, 
A/Hong Kong/4801/2014/H3N2, B/Texas/2/2013/
Victor ia system, and B/Phuket/1307/2013 /
Yamagata system strains, was performed using an 
originally constructed EIA system (See Materials and 
Methods for details). The measurements were 
repeated five times. 







　水素発生装置（スイソニア）から発生する水素ガス（濃度 0.1%～ 0.3%）を含む蒸気混合ガス XENを鼻カ
ニューラで吸入した。吸入後、A型および B型インフルエンザウイルス由来の hemagglutinin（HA）抗原に
対する唾液中 IgA2抗体価を自主開発の酵素免疫測定法で解析した。その結果、XEN吸入 15分後、A型イ
ンフルエンザウイルス株（A/California/7/2009/H1N1と A/Hong Kong/4801/2014/H3N2）由来の HA抗原
に対する唾液中 IgA2抗体価は、吸入前と比較して有意に増加した（P=0.028および P=0.047）。さらに、XEN
吸入 15分後、A型と B型インフルエンザウイルス株（A/Singapore/GP1908/2015/H1N1、A/Hong 
Kong/4801/2014/H3N2、B/Texas/2/2013/Victoria system、B/Phuket/1307/2013 /Yamagata system）
由来の HA抗原（ワクチンタイプ）に対する唾液中 IgA2抗体価も吸入前と比較して有意に増加した
（P=0.039）。以上の結果から、XENには HA抗原に対する唾液中 IgA2抗体価の増強作用があることがわか
った。
キーワード ：酵素免疫測定法、ヘマグルチニン、唾液 IgA2、水素ガス含有蒸気混合ガス、XEN
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